Symposium 3 | Metabolic Crossroads: Lipids, Liver Function, and Microbiota Interactions
ESCI Council: Paula Macedo and Marcin Krawczyk
ESCI YRC: Harshitha Shanmugam
Invited Organizer(s): Federico Gatto, Edoardo Giannini, and Piero Portincasa
Meeting room: To be decided
13.30-15.00 Session 3.1. Lipid Dysfunction in Metabolic Disorders
Chairs: Piero Portincasa, Paula Macedo
13.30-13.50 Adipose Tissue Dysfunction: A Central Driver of MASLD, by Amalia Gastaldelli (Pisa, Italy)
13.50-14.10 Clinical Presentation of LAL-Deficiency, a Rare Dislipidemia with Liver Involvement, by Livia Pisciotta (Genoa, Italy)
14.10-14.30 Statins and Nonalcoholic fatty liver disease in the era of precision medicine, by Fabio Nascimbeni (Modena, Italy)
14.30-14.45 Oral presentation
14.45-15.00 Oral presentation
15.00-15.30 Coffee-break
15.30-17.00 Session 3.2. Microbiota-Liver Interactions in Metabolic Health
Chairs: Federico Gatto, Edoardo Giannini
15.30-16.00 Microbiome Changes and Syndrome of Bacterial Overgrowth in Patients with Dyslipidemia, by Khrystyna Kvit (Lviv, Ukraine)
16.00-16.30 Probiotic Lactobacillus rhamnosus Mitigates Ductular Reaction in Mcpip1-Deficient Mice via Modulation of Gut-Liver Crosstalk, by Jerzy Kotlinowski (Krakow, Poland)
16.30-16.45 Oral presentation
16.45-17.00 Oral presentation
17.00-17.30 Opening ceremony
17.30-18.30 Opening lecture
18.30 Welcome drink
08.15-09.00 Pas gras outreach activity
09.00-10.30 Session 3.3. Complexities in Liver and Metabolic Disorders
Chairs: Marcin Krawczyk, Harshitha Shanmugam
09.00-09.30 MetALD: Challenges of Coexisting Metabolic Dysfunction and Alcohol Toxicity in the Liver, by Gyorgy Baffy (Boston, USA)
09.30-10.00 Linking MASH to Chronic Kidney Disease, by Sonia Najjar (Ohio, USA)
10.00-10.15 Oral presentation
10.15-10.30 Oral presentation
10.30-11.00 Coffee-break
11.00-12.30 Session 3.4. Gut-Liver Axis and Therapeutics
Chairs: Jerzy Kotlinowski, Michał Żorniak
11.00-11.30 Next Generation Probiotics and MASLD, by Giovanni Sarnelli (Napoli, Italy)
11.30-12.00 Genetic Profiling for Carbohydrate Maldigestion in Irritable Bowel Syndrome, by Mauro D’Amato (Bari, Italy)
12.00-12.15 Oral presentation
12.15-12.30 Oral presentation
12.30-13.30 Poster session
13.30-14.30 Lunch
14.30-16.00 Session 3.5. Hormonal and Lifestyle Modulators in Obesity and Liver Health
Chairs: Mauro D’Amato, Diego Ferone
14.30-15.00 Hormonal, Metabolic, and Gastrointestinal Motility Changes in Subjects with Obesity Undergoing Sleeve Gastrectomy, by Gabriella Garutti (Bari, Italy)
15.00-15.30 Navigating the Metabolic Crossroads: Personalized Lifestyle Insights from EU Projects on Obesity and Subclinical Liver Function, by Harshitha Shanmugam and Mohamad Khalil (Italy)
15.30-15.45 Oral presentation
15.45-16.00 Oral presentation
15.30-16.30 Sponsored symposia
16.30-17.30 Poster session and coffee-break
17.30-18.30 Satellite symposia
20.00 Congress dinner
09.00-10.30 Session 3.6. Lipid Regulation and Energy Balance
Chairs: Silvia Vilares Conde, Luca Miele
09.00-09.30 Pancreatic Steatosis: The Fatty Time Bomb Fueling Diabetes or More?, by Michał Żorniak (Gliwice, Poland)
09.30-10.00 New Framework for the Diagnosis, Staging, and Management of Obesity in Adults, by Gema Frühbeck Martínez (Spain)
10.00-10.15 Oral presentation
10.15-10.30 Oral presentation
10.30-11.00 Coffee-break
11.00-12.30 Session 3.7. Personalized Approaches and Sex-Specific Insights
Chairs: Gabriella Garutti, Livia Pisciotta
11.00-11.30 Sex Matters in Obesity and Longevity: Unveiling Metabolic Disparities, by Maria Paula Macedo (Lisbon, Portugal)
11.30-12.00 MASLD Therapies on the Horizon: Shaping the Future of Liver Disease Management, by Luca Miele (Rome, Italy)
12.00-12.15 Oral presentation
12.15-12.30 Oral presentation
12.30-14.00 Poster session and lunch
14.00-14.45 Closing ceremony
15.00-17.00 Multi-focus plenary session, ESCI Prices and Medal
